2023
Entrant
Category
Client's Name
Country / Region
Unlocking the Proteome -The NULISA™ Platform sets a new standard in proteomic analysis with attomolar sensitivity, allowing for unprecedented biomarker detection and quantitation.
By leveraging a proprietary sequential immunocomplex capture and release mechanism and the latest advances in Next Generation Sequencing (NGS), the NULISA technology provides both ultra-high sensitivity and scalable multiplexing.
Credits
Entrant
FutureBrand
Category
Advertising - Brand & Corporate Identity
Country / Region
United States
Entrant
Shoot You Ltd
Category
Video, Commercial & Film - Animation
Country / Region
United Kingdom
Entrant
Faktory
Category
Video, Commercial & Film - TV Commercial
Country / Region
United States
Entrant
SFC Group
Category
Marketing Campaign - Integrated Marketing Campaign
Country / Region
United States